Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Precision Drilling
PDS
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
OKUR OnKure Therapeutics
- 1.920
- -0.080-4.00%
Close May 9 16:00 ET
- 1.920
- 0.0000.00%
Post 16:05 ET
25.94MMarket Cap-0.44P/E (TTM)
2.050High1.830Low185.91KVolume1.990Open2.000Pre Close358.90KTurnover3.76%Turnover RatioLossP/E (Static)13.51MShares19.99952wk High0.29P/B9.50MFloat Cap1.83052wk Low--Dividend TTM4.95MShs Float171.799Historical High--Div YieldTTM11.00%Amplitude1.830Historical Low1.930Avg Price1Lot Size
OnKure Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 72.92%17M | 47.25%54.39M | 260.07%33.8M | -77.67%4.66M | 66.12%14.34M | 12.33%9.83M | 24.08%36.93M | -21.11M | 20.89M | 8.63M |
| Selling and administrative expenses | 215.26%3.99M | 119.78%10.59M | 74.93%-3.56M | -48.25%3.76M | 220.63%3.59M | 2.93%1.27M | 23.44%4.82M | ---14.22M | --7.27M | --1.12M |
| -General and administrative expense | 215.26%3.99M | 119.78%10.59M | 74.93%-3.56M | -48.25%3.76M | 220.63%3.59M | 2.93%1.27M | 23.44%4.82M | ---14.22M | --7.27M | --1.12M |
| Research and development costs | 51.90%13.01M | 36.37%43.8M | 641.91%37.36M | -93.36%904K | 43.09%10.75M | 13.86%8.57M | 24.18%32.12M | ---6.89M | --13.62M | --7.51M |
| Operating profit | -72.92%-17M | -47.25%-54.39M | -260.07%-33.8M | 77.67%-4.66M | -66.12%-14.34M | -12.33%-9.83M | -24.08%-36.93M | 21.11M | -20.89M | -8.63M |
| Net non-operating interest income expense | 264.41%1.08M | 5.55%1.71M | -54.77%204K | 304.11%295K | 538.98%1.62M | 451K | ||||
| Non-operating interest income | 264.41%1.08M | 24.03%2.01M | ---- | ---- | -49.00%230K | 304.11%295K | 538.98%1.62M | ---- | ---- | --451K |
| Non-operating interest expense | ---- | --300K | ---- | ---- | --26K | ---- | --0 | ---- | ---- | --0 |
| Other net income (expense) | -42.55%972K | 1.69M | ||||||||
| Other non- operating income (expenses) | ---- | ---- | ---- | -42.55%972K | ---- | ---- | ---- | ---- | --1.69M | ---- |
| Income before tax | -67.00%-15.93M | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M |
| Income tax | ||||||||||
| Net income | -67.00%-15.93M | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M |
| Net income continuous Operations | -67.00%-15.93M | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | --18.52M | ---19.2M | ---8.18M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -67.00%-15.93M | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -67.00%-15.93M | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M |
| Basic earnings per share | -66.46%-1.19 | -477.23%-15.28 | -198.66%-1.37 | 80.77%-0.2768 | -72.79%-1.0599 | -9.87%-0.7149 | -19.65%-2.6471 | 1.3886 | -1.439 | -0.6134 |
| Diluted earnings per share | -66.46%-1.19 | -477.23%-15.28 | -198.66%-1.37 | 80.77%-0.2768 | -72.79%-1.0599 | -9.87%-0.7149 | -19.65%-2.6471 | 1.3886 | -1.439 | -0.6134 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now